HCW Biologics Ownership | Who Owns HCW Biologics?


OverviewRevenueFinancialsChart

HCW Biologics Ownership Summary


HCW Biologics is owned by 0.06% institutional investors, 49.55% insiders, and 50.39% retail investors. Avantax planning partners is the largest institutional shareholder, holding 0.74% of HCWB shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.54% of its assets in HCW Biologics shares.

HCWB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHCW Biologics0.06%49.55%50.39%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avantax planning partners279.54K0.74%$124.70K
Geode capital management181.96K0.48%$81.20K
Cresset asset management131.99K0.35%$58.88K
Pullen investment management85.12K0.23%$55.07K
Blackrock42.66K0.11%$27.60K
Blackrock funding, inc. /de42.99K0.11%$19.18K
Vanguard group37.68K0.10%$16.80K
Ae wealth management30.00K0.08%$13.38K
State street21.45K0.06%$9.57K
Renaissance15.00K0.04%$6.69K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pullen investment management85.12K0.05%$55.07K
Avantax planning partners279.54K0.00%$124.70K
Cresset asset management131.99K0.00%$58.88K
Ae wealth management30.00K0.00%$13.38K
Jane street group---
Two sigma investments, lp---
Blackrock42.66K-$27.60K
Bank of america corp /de/156.00-$101.00
Hightower advisors---
Northern trust10.21K-$6.60K

Top Buyers

HolderShares% AssetsChange
Renaissance15.00K-15.00K
Citadel advisors13.88K-13.88K
Ae wealth management30.00K0.00%-
Northern trust10.21K--
Pullen investment management85.12K0.05%-

Top Sellers

HolderShares% AssetsChange
Armistice capital---2.02M
Hightower advisors---180.81K
Hrt financial lp---46.50K
Bridgeway capital management---34.70K
Xtx topco---34.00K

New Positions

HolderShares% AssetsChangeValue
Renaissance15.00K-15.00K$6.69K

Sold Out

HolderChange
Jpmorgan chase-9.00
Wells fargo & company/mn-141.00
Ubs group-4.83K
Two sigma investments, lp-12.08K
Virtu financial-15.62K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202515-16.67%1,155,570-63.07%-0.09%775.00%2-66.67%
Dec 31, 20246-62.50%738,597-36.28%120.79%1-75.00%2-50.00%
Sep 30, 202416-11.11%1,159,083-4.39%328.89%4-42.86%4-20.00%
Jun 30, 202418-5.26%1,212,33710.20%334.74%7-5-
Mar 31, 2024195.56%1,100,1103.30%334.85%7-36.36%566.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr6.08K0.54%1.00
Fidelity Extended Market Index139.50K0.31%47.66K
Bridgeway Ultra-Small Company Market34.70K0.08%-50.00K
Fidelity Total Market Index29.02K0.06%-
Fidelity Series Total Market Index24.52K0.05%3.22K
Fidelity Nasdaq Composite Index23.27K0.05%-
iShares Micro-Cap ETF881.000.05%-
Spartan Extended Market Index Pool F13.60K0.03%800.00
Spartan Extended Market Index Pool E13.60K0.03%800.00
NT Ext Equity Mkt Idx Fd - L9.06K0.02%-

Recent Insider Transactions


DateNameRoleActivityValue
May 16, 2025Wong Hing C Chief Executive OfficerBuy$60.00K
May 16, 2025Winer Gary M-Buy$10.00K
May 16, 2025GARRETT SCOTT T-Buy$100.00K
May 08, 2025Winer Gary M-Buy$60.01K
May 07, 2025Winer Gary M-Buy$30.00K

Insider Transactions Trends


DateBuySell
2025 Q212-
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q316-

HCWB Ownership FAQ


Who Owns HCW Biologics?

HCW Biologics shareholders are primarily institutional investors at 0.06%, followed by 49.55% insiders and 50.39% retail investors. The average institutional ownership in HCW Biologics's industry, Biotech Stocks , is 63.96%, which HCW Biologics falls below.

Who owns the most shares of HCW Biologics?

HCW Biologics’s largest shareholders are Avantax planning partners (279.54K shares, 0.74%), Geode capital management (181.96K shares, 0.48%), and Cresset asset management (131.99K shares, 0.35%). Together, they hold 1.57% of HCW Biologics’s total shares outstanding.

Does Blackrock own HCW Biologics?

Yes, BlackRock owns 0.11% of HCW Biologics, totaling 42.66K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 27.6K$. In the last quarter, BlackRock decreased its holdings by -3.372K shares, a -7.33% change.

Who is HCW Biologics’s biggest shareholder by percentage of total assets invested?

Pullen investment management is HCW Biologics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 85.12K HCW Biologics shares, valued at 55.07K$.

Who is the top mutual fund holder of HCW Biologics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of HCW Biologics shares, with 0.54% of its total shares outstanding invested in 6.08K HCW Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools